3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Prostatic Neoplasms
17
Neoplasms
13
Breast Neoplasms
12
Neuroendocrine Tumors
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Multiple Myeloma
4
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Esophageal Squamous Cell Carcinoma
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Cells, Circulating
2
Nasopharyngeal Carcinoma
2
Multiple Pulmonary Nodules
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Hypoxia
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Methotrexate
21
Ifosfamide
21
Cyclophosphamide
19
Doxorubicin
17
Cisplatin
14
Filgrastim
13
Gemcitabine
12
Etoposide
11
Leucovorin
9
apatinib
8
fludarabine
7
glucarpidase
6
Vincristine
6
Temozolomide
6
Radiotherapy
6
Nivolumab
6
Neoadjuvant Therapy
6
Drug Therapy
6
Carboplatin
6
regorafenib
5
cabozantinib
5
Zoledronic Acid
5
Topotecan
5
Mesna
5
Irinotecan
5
Granulocyte Colony-Stimulating Factor
5
Docetaxel
5
pembrolizumab
4
pegfilgrastim
4
camrelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Osteosarcoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled